Eikon Therapeutics, Inc. Common Stock (EIKN)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Eikon Therapeutics, Inc. Common Stock (EIKN) is listed on Nasdaq, where it has traded since February 5, 2026.
- Listed On
- Nasdaq
- Listed Since
- February 5, 2026
- Employees
- 384
- Market Cap
- $429M
About Eikon Therapeutics, Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 73 institutions reported holding EIKN, with 26.5 million shares worth $344.3 million in aggregate. The largest reported holder was FMR, with 5.0 million shares worth $65.2 million. Of the 5 largest holders listed below, 3 added shares and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| FMR | 4,993,906 | $65M | Added 30.16% |
| BlackRock | 4,281,425 | $56M | Added 28.98% |
| T. Rowe Price | 2,600,309 | $34M | Added 18.29% |
| Foresite Capital Management IV | 1,943,682 | $25M | Unchanged |
| Merck & Co | 1,666,666 | $22M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is EIKN?
Eikon Therapeutics, Inc. Common Stock (EIKN) is listed on Nasdaq, where it has traded since February 5, 2026.
Who are the largest institutional holders of EIKN?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of EIKN were FMR, BlackRock and T. Rowe Price.
How many institutions own EIKN?
73 institutions reported a position in EIKN for the quarter ended June 30, 2026, worth $344.3 million in total.
Did institutions buy or sell EIKN last quarter?
Of the 5 largest reported holders, 3 added shares and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for EIKN.
Every reported institutional holder, plus insider and congressional trades in EIKN, on SentiSense.